Page last updated: 2024-08-16

thalidomide and cytochrome c-t

thalidomide has been researched along with cytochrome c-t in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Domschke, W; Gockel, HR; Heidemann, J; Kucharzik, T; Lügering, A; Lügering, N; Schmidt, M	1
Du, GJ; Lin, HH; Wang, MW; Xu, QT	1

Other Studies

2 other study(ies) available for thalidomide and cytochrome c-t

Article	Year
Thalidomide induces apoptosis in human monocytes by using a cytochrome c-dependent pathway. Journal of immunology (Baltimore, Md. : 1950), 2004, Apr-15, Volume: 172, Issue:8 Topics: Apoptosis; Apoptosis Regulatory Proteins; Caspase 9; Caspases; Cells, Cultured; Cytochromes c; Enzyme Activation; Fas Ligand Protein; fas Receptor; Humans; Membrane Glycoproteins; Mitochondria; Monocytes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Tumor Necrosis Factor; Signal Transduction; Thalidomide; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha	2004
Thalidomide inhibits growth of tumors through COX-2 degradation independent of antiangiogenesis. Vascular pharmacology, 2005, Volume: 43, Issue:2 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cytochromes c; Dose-Response Relationship, Drug; Female; Glutathione; HeLa Cells; HL-60 Cells; Humans; K562 Cells; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Proto-Oncogene Proteins c-bcl-2; Thalidomide; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2005

Article

Year

Thalidomide induces apoptosis in human monocytes by using a cytochrome c-dependent pathway.

Journal of immunology (Baltimore, Md. : 1950), 2004, Apr-15, Volume: 172, Issue:8

Topics: Apoptosis; Apoptosis Regulatory Proteins; Caspase 9; Caspases; Cells, Cultured; Cytochromes c; Enzyme Activation; Fas Ligand Protein; fas Receptor; Humans; Membrane Glycoproteins; Mitochondria; Monocytes; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptors, Tumor Necrosis Factor; Signal Transduction; Thalidomide; TNF-Related Apoptosis-Inducing Ligand; Tumor Necrosis Factor-alpha

2004

Thalidomide inhibits growth of tumors through COX-2 degradation independent of antiangiogenesis.

Vascular pharmacology, 2005, Volume: 43, Issue:2

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cyclooxygenase 2; Cytochromes c; Dose-Response Relationship, Drug; Female; Glutathione; HeLa Cells; HL-60 Cells; Humans; K562 Cells; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Proto-Oncogene Proteins c-bcl-2; Thalidomide; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2005